About GEFTIB GEFITINIB TABLETS
Specifications:-
- Brand Name: GEFTIB
- Content: Gefitinib
- Strengths: 250 mg
- Form : Tablets
- Packing: Pack of 30 tablets
- Manufactured By: Glenmark
Note :- GEFTIB Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............
Targeted Cancer TherapyGEFTIB Gefitinib Tablets are specifically developed to target cancer cells, offering an advanced solution for patients diagnosed with non-small cell lung cancer. The active ingredient, gefitinib, works by inhibiting the growth of malignant cells, providing a streamlined treatment option. Consultation with a healthcare professional is essential before starting therapy, ensuring the medicine aligns with your medical requirements.
Quality Assurance for DistributorsAs a trusted product distributed, exported, and supplied across India, GEFTIB Gefitinib Tablets maintain high standards of quality and authenticity. Distributors and traders benefit from consistent supply channels and assurance in product efficacy, making it an ideal choice for the wider oncology medicine market.
FAQs of GEFTIB GEFITINIB TABLETS:
Q: How should GEFTIB Gefitinib Tablets be taken for optimal results?
A: GEFTIB Gefitinib Tablets are typically taken once daily, with or without food, as prescribed by your oncologist. It is vital to follow the specific dosage and instructions provided by your healthcare provider to ensure maximum efficacy and reduced risk of side effects.
Q: What are the main ingredients and therapeutic function of GEFTIB Gefitinib Tablets?
A: The primary ingredient in GEFTIB tablets is gefitinib, which functions as an anti-cancer agent. It works by interfering with proteins involved in the growth and spread of cancer cells, particularly effective in certain types of lung cancer.
Q: When is GEFTIB Gefitinib recommended as a treatment option?
A: GEFTIB Gefitinib Tablets are commonly recommended for patients diagnosed with advanced or metastatic non-small cell lung cancer, especially those whose tumors have specific mutations. The decision to use gefitinib should be determined by an oncologist, based on individual patient profiles and genetic testing.
Q: Where can GEFTIB Gefitinib Tablets be sourced in India?
A: These tablets are widely available through authorized distributors, exporters, suppliers, traders, and wholesalers across India. To ensure safety and authenticity, purchase only from reputable, licensed pharmaceutical providers.
Q: What is the process for starting treatment with GEFTIB Gefitinib?
A: Beginning therapy with GEFTIB involves consultation with a qualified oncologist, confirmation of lung cancer type (and relevant mutations), and careful consideration of medical history. Your doctor will initiate the medication and monitor your progress throughout the treatment period.
Q: How do patients benefit from using GEFTIB Gefitinib Tablets?
A: Patients benefit from GEFTIB through targeted therapy, which can slow or halt the progression of cancer, potentially improving survival and quality of life. The tablet form offers convenient dosing and manageable treatment integration into daily routines.